🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral vs injectable GLP-1: bioavailability and efficacy comparison — need advice Page 2

Oral vs injectable GLP-1: bioavailability and efficacy comparison — need advice

mike_mealprep Sun, Dec 29, 2024 at 3:34 PM 12 replies 1,712 viewsPage 2 of 3
CryptoCarl
Member
789
3,456
May 2024
Arizona
Dec 29, 2024 at 6:24 PM#6

Wait there's going to be a 50mg oral version?? That would be a game changer honestly. I would switch in a heartbeat if the efficacy matched injectable.

Last edited: Dec 29, 2024 at 10:24 PM
6 0CryptoCarl, MariaRD, AussieAnna and 3 others
Reply Quote Save Share Report
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Dec 29, 2024 at 6:41 PM#7

For the travel issue specifically — a few tips that helped me keep using injectable while traveling constantly:

  • FRIO insulin cooling wallets — no refrigeration needed, just soak in water. Keeps pens cool for 48-72 hours.
  • TSA has NEVER given me an actual problem with my Wegovy pens. I keep them in a clear bag with the prescription label visible. Just tell them it's medication.
  • Most hotels will put medication in their kitchen fridge if you ask the front desk.
  • Wegovy pens are actually stable at room temperature (up to 86°F/30°C) for up to 28 days, so for short trips you might not even need refrigeration.
Last edited: Dec 29, 2024 at 8:41 PM
21 17Dr.DermMIA, fiona_VT, denise_HTX and 18 others
Reply Quote Save Share Report
maria_elpaso
Member
312
1,456
Sep 2024
El Paso, TX
Dec 29, 2024 at 6:58 PM#8

Ok this is all super helpful. It sounds like switching to oral at my current dose (1.7mg injectable) would be a downgrade in efficacy, and the daily fasting requirement might actually be MORE of a hassle than weekly injections.

I think I'll stick with injectable and try the FRIO wallet for travel. And keep my eye out for when/if the higher-dose oral formulation gets approved.

Thanks everyone — saved me from making a mistake! 🙏

46 12TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 43 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Dec 29, 2024 at 7:15 PM#9

Smart decision. One more data point: the oral 50mg formulation from OASIS 1 also had higher rates of GI side effects compared to injectable 2.4mg in cross-trial comparisons. The 50mg pill delivers a LOT of semaglutide to the stomach lining even if only 1% is absorbed systemically, and that local GI exposure may cause more nausea/vomiting. Something to factor in if/when it becomes available.

— pharma_data_guy | PharmD | GLP-1 pharmacology nerd
23 3lori_vegas, Dr.PulmRoch, maya_sedona and 20 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register